We are live on ! Find out more
TCMG

TSP Capital Management Group Portfolio holdings

AUM $418M
1-Year Est. Return 68.45%
This Fund
S&P 500
This Quarter Est. Return
-2.64%
1 Year Est. Return
+68.45%
3 Year Est. Return
+177.76%
5 Year Est. Return
+247.33%
10 Year Est. Return
+1,387.97%
AUM
$218M
AUM Growth
-$12.2M
Cap. Flow
-$231M
Cap. Flow %
-105.7%
Top 10 Hldgs %
40.6%
Holding
76
New
–
Increased
–
Reduced
–
Closed
74

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$11.8M
2
SE
Spectra Energy Corp Wi
SE
+$11.3M
3
DD
Du Pont De Nemours E I
DD
+$11M
4
CMCSA icon
Comcast
CMCSA
+$9.59M
5
XYL icon
Xylem
XYL
+$8.65M

Sector Composition

Rank Sector Weight
1 Healthcare 18.18%
2 Materials 14.56%
3 Communication Services 12.88%
4 Industrials 9.3%
5 Utilities 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
76
Philip Morris
PM
$297B
– –
-3,058
Closed -$258K
1 2 3
4

Similar funds

FFA
Florida Financial Advisors Tampa, Florida $418M AUM 41.28% 1-Year Est. Return
WPI
Walter Public Investments Westmount, Canada $418M AUM 16.41% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VIS
Vega Investment Solutions Paris, France $418M AUM
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return

TSP Capital Management Group's Q3 2014 Portfolio in Review

As of Q3 2014, TSP Capital Management Group held 76 positions worth $218M, down 5.3% from $230M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

TSP Capital Management Group withdrew a net $231M in Q3 2014, closing 74 positions. Its most notable exit was Celldex Therapeutics, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Materials and Communication Services.

  • TSP Capital Management Group fully exited Celldex Therapeutics in Q3 2014, selling an estimated $11.8M.
  • TSP Capital Management Group's ten largest holdings make up 41% of its $218M portfolio in Q3 2014.
  • TSP Capital Management Group opened 0 new positions and closed 74 in Q3 2014.
  • TSP Capital Management Group's portfolio value fell 5.3% quarter-over-quarter to $218M.

Based on TSP Capital Management Group's 13F filing for Q3 2014, filed 10 Nov 2014.